Professor, Medicine, Oregon Health and Science University School of Medicine
Hematology
Dr. Thomas G. Deloughery, MD
|
|
Give Review
Dr. Thomas G. Deloughery works in the field of Hematology. He attended Indiana University School of Medicine. Indiana University School of Medicine is ranked 45 in research and 47 in primary care medicine He received awards:"America's Top Doctors", "Portland Monthly Magazine", "CMS Meaningful Use Stage 1 Certification" and "Top MD". Thomas Deloughery has written publications. He has 68 publications published with PubMed. The lastest publication is: 'Transfusion and blood component therapy: key facts.' Thomas G. Deloughery, MD is registered with Medicare.
Publications
- Clinical decision support reduces overuse of red blood cell transfusions: interrupted time series analysis.
- Bevicizumab and Thrombosis: Some answers but questions remain.
- Microcytic Anemia.
- Randomised controlled trial: extended-duration dabigatran is non-inferior to warfarin and more effective than placebo for symptomatic VTE.
- Safety and efficacy of prothrombin complex concentrates for the treatment of coagulopathy after cardiac surgery.
- The International Normalized Ratio overestimates coagulopathy in stable trauma and surgical patients.
- Paroxysmal Nocturnal Hemoglobinuria: A Red Clot Syndrome.
- Patients with disorders of Thrombosis and hemostasis.
- The use of recombinant factor VIIa in warfarin patients with traumatic Brain injury: a retrospective case-control study.
- Cryopreserved deglycerolized blood is safe and achieves superior tissue oxygenation compared With refrigerated red blood cells: A prospective randomized pilot study.
- Bleeding and thrombosis in Acute promyelocytic leukemia.
- Direct Thrombin Inhibitors for the Treatment of Venous ThromboEmbolism: Analysis of the Dabigatran versus Warfarin Clinical Trial.
- Estrogen and Thrombosis: Controversies and common sense.
- Practical aspects of the oral new anticoagulants.
- Symptomatic perioperative venous thromboEmbolism is a frequent complication in patients with a history of deep vein thrombosis.
- Management of acquired bleeding problems in Cancer patients.
- Venous thrombotic emergencies.
- Coagulation management in massive bleeding.
- Logistics of massive transfusions.
- Thrombocytopenia and other hot topics.
- Iron: The fifth horseman of the apocalypse?
- Incidence and risk factors for venous thromboembolic disease in podiatric surgery.
- First episode and recurrent venous thromboEmbolism: who is identifiably at risk?
- Splenectomy for Immune thrombocytopenic purpura: surgery for the 21st century.
- Update in hematology.
- Safety of inferior vena cava filter retrieval in anticoagulated patients.
- Venous thromboEmbolism in the ICU and reversal of bleeding on anticoagulants.
- Critical care clotting catastrophies.
- Phase II study of transdermal estradiol in androgen-independent proState carcinoma.
- A phase I study of 5-fluorouracil, leucovorin, and celecoxib in patients with incurable colorectal Cancer.
- Coagulation defects in trauma patients: etiology, recognition, and therapy.
- Effects of Ginkgo biloba on exhaled nasal nitric oxide during normobaric hypoxia in humans.
- Pulmonary and intracerebral plasmacytomas in a patient Without multiple myeloma: a case report.
- Homozygous hereditary resistance to activated protein C presenting as cerebral venous Thrombosis.
- International normalized ratio in anticoagulant therapy: understanding the issues.
- Acute promyelocytic leukaemia in the all trans retinoic acid era.
- Natural killer cell Leukemia as a cause of peripheral neuropathy and meningitis: case report.
- Common mutation in methylenetetrahydrofolate reductase. Correlation With homocysteine metabolism and late-onset vascular disease.
- Invasive line placement in critically ill patients: do hemostatic Defects matter?
- Natural killer cell Leukemia presenting with a peripheral neuropathy.
- DVT prophylaxis in total hip replacement.
- The Hypercoagulable states: diagnosis and management.
- Evolutionary conservation of the AU-rich 3' untranslated region of messenger RNA.
- Interleukin-1 stimulation stabilizes GM-CSF mRNA in human vascular endothelial cells: preliminary studies on the role of the 3' AU rich motif.
- Therapeutic efficacy of Aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, wi...
- Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency.
- Anticoagulant therapy in special circumstances.
- Pulmonary hemorrhage in a Hemophiliac simulating a lung neoplasm.
- Fatal cerebroEmbolism from nonbacterial thrombotic endocarditis in a trauma patient: case report and review.
- Coagulation abnormalities and cardiovascular disease.
- Management of bleeding With uremia and liver disease.
- Higher total homocysteine concentrations and lower folate concentrations in premenopausal black women than in premenopausal white women.
- Role of a common mutation in the homocysteine regulatory enzyme methylenetetrahydrofolate reductase in ischemic stroke.
- Transfusion and blood component therapy: key facts.
- A DNase I-hypersensitive site in the second intron of the murine IL-4 gene defines a mast cell-specific enhancer.
- Abnormal phospholipid molecular species of erythrocytes in sickle cell Anemia.
- Clinical one-year outcomes after stenting in Acute myocardial infarction.
- High dose calcitriol may reduce Thrombosis in cancer patients.
- The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate Cancer: A multivariate analysis of Sout...
- Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole: Case report and review of the literature.
- Management of bleeding emergencies: when to use recombinant activated factor VII.
- Moderate hypoxia suppresses exercise-induced procoagulant changes.
- Severe bleeding in a woman heterozygous for the fibrinogen gammaR275C mutation.
- A retrospective case control study of recombinant factor VIIa in patients With intracranial haemorrhage caused by trauma.
- Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous Thrombosis.
- Metastatic breast cancer manifested as refractory Anemia and gastric polyps.
- Menstrual regulation in women With von Willebrand''s disease.
Schools
Indiana University School Of Medicine
Or Health Science University Hospital
University Ca Irvine Med Center
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Aortic Embolism and Thrombosis
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- CHAMPVA
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- First Choice Health PPO
- First Health (Coventry Health Care) PPO
- Health Plan of Oregon PPO
- Medicare Advantage PFFS
- HealthSmart
- Humana
- Kaiser Permanente
- Medicaid
- Medicare MCR
- ODS Health Plan
- Preferred PSN
- Heritage Plus
- Heritage Signature
- Preferred PPO
- Preferred Provider Network PPN
- Tricare
- Choice Plus POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- America's Top Doctors
- Portland Monthly Magazine
- CMS Meaningful Use Stage 1 Certification
- Top MD
Education
-
Oregon Health & Science University -
University of California Irvine -
Indiana University School of Medicine
Drug Facts
| NPI NUMBER | 1063427581 | |
| NPPES Provider LastName | DELOUGHERY | |
| NPPES Provider FirstName | THOMAS | |
| NPPES Provider ZIPCode | 972393011 | |
| NPPES Provider State | OR | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 545.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 83.0 | |
| Percent Opioid Claims | 15.23 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1063427581 |
| Last Name Of The Provider | DELOUGHERY |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
|
Dr. Phuong T. Doan, MD |
|
Dr. Jeffrey I. Menashe, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Ralph E. Weinstein, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gerald M. Segal, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lucy R. Langer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stacy K. Lewis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael C. Heinrich, MD |
|
|
Dr. Andy I. Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen E. Spurgeon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cristina P. Rodriguez, MD |
|
|
Dr. Melinda C. Myzak, MD |
|
|
Dr. Anthony N. Van Ho, MD |